XBiotech Inc. (XBIT) Net income 2016–2025
XBiotech Inc. (XBIT) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$45.5MFY2025 · since FY2016: -$52.8M → -$45.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$45.5M | -18.2% |
| FY2024 | -$38.5M | -56.9% |
| FY2023 | -$24.6M | +25.4% |
| FY2022 | -$32.9M | -88.9% |
| FY2021 | -$17.4M | -55.2% |
| FY2020 | -$11.2M | -101.7% |
| FY2019 | $668.6M | +3263.2% |
| FY2018 | -$21.1M | +36.2% |
| FY2017 | -$33.1M | +37.2% |
| FY2016 | -$52.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More XBIT financial trends
XBIT RevenueXBIT Net marginXBIT Gross profitXBIT Gross marginXBIT Operating incomeXBIT Operating marginXBIT Operating cash flowXBIT Free cash flowXBIT Capital expendituresXBIT Return on equityXBIT Stock buybacksXBIT Dividends paidXBIT Total assetsXBIT Total liabilitiesXBIT Shareholders’ equityXBIT overview →